Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:GUTSNASDAQ:KRMDNASDAQ:LUCD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.58-9.2%$2.79$1.57▼$8.44$3.18M1.89184,348 shs110,347 shsGUTSFractyl Health$2.14+12.0%$1.71$0.87▼$5.00$104.81M1.85326,182 shs365,409 shsKRMDKORU Medical Systems$3.38+4.0%$2.85$1.86▼$5.05$155.96M0.43136,520 shs241,267 shsLUCDLucid Diagnostics$1.26$1.28$0.71▼$1.80$136.32M1.31603,797 shs3.05 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-10.23%-50.50%-54.07%-70.74%GUTSFractyl Health0.00%+3.88%+21.94%+71.20%-60.22%KRMDKORU Medical Systems0.00%+4.64%+24.26%+20.28%+51.57%LUCDLucid Diagnostics0.00%-2.33%-5.26%-17.11%+74.54%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical3.0946 of 5 stars3.55.00.00.02.40.01.3GUTSFractyl Health2.3244 of 5 stars3.52.00.00.03.30.00.0KRMDKORU Medical Systems3.3369 of 5 stars3.55.00.00.00.02.50.6LUCDLucid Diagnostics3.4628 of 5 stars3.65.00.00.03.21.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$56.003,444.30% UpsideGUTSFractyl Health 3.00Buy$11.00414.02% UpsideKRMDKORU Medical Systems 3.00Buy$4.5033.14% UpsideLUCDLucid Diagnostics 3.20Buy$3.55181.75% UpsideCurrent Analyst Ratings BreakdownLatest AEMD, GUTS, LUCD, and KRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.50 ➝ $7.755/15/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.005/14/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.005/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.504/21/2025LUCDLucid DiagnosticsAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.00 ➝ $7.504/15/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.004/11/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.00 ➝ $3.003/26/2025LUCDLucid DiagnosticsCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$2.00 ➝ $2.003/25/2025LUCDLucid DiagnosticsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.003/24/2025LUCDLucid DiagnosticsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $3.00(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K5.57N/AN/A$17.54 per share0.09GUTSFractyl Health$90K1,164.64N/AN/A$0.59 per share3.63KRMDKORU Medical Systems$33.65M4.63N/AN/A$0.37 per share9.14LUCDLucid Diagnostics$4.35M31.34N/AN/A($0.78) per share-1.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)GUTSFractyl Health-$68.69M-$1.85N/AN/AN/A-73,864.52%-228.66%-76.74%8/13/2025 (Estimated)KRMDKORU Medical Systems-$6.07M-$0.11N/AN/AN/A-15.09%-30.43%-19.41%8/6/2025 (Estimated)LUCDLucid Diagnostics-$45.53M-$1.34N/AN/AN/A-1,699.86%N/A-124.27%8/11/2025 (Estimated)Latest AEMD, GUTS, LUCD, and KRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/13/2025Q1 2025GUTSFractyl Health-$0.49-$0.49N/A-$0.49N/AN/A5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80GUTSFractyl Health4.612.502.50KRMDKORU Medical Systems0.012.442.02LUCDLucid DiagnosticsN/A0.750.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%GUTSFractyl HealthN/AKRMDKORU Medical Systems58.60%LUCDLucid Diagnostics74.01%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%GUTSFractyl HealthN/AKRMDKORU Medical Systems20.60%LUCDLucid Diagnostics6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.01 million1.99 millionNo DataGUTSFractyl Health10248.98 millionN/AN/AKRMDKORU Medical Systems8046.14 million36.64 millionOptionableLUCDLucid Diagnostics70108.19 million100.83 millionNo DataAEMD, GUTS, LUCD, and KRMD HeadlinesRecent News About These CompaniesLucid Diagnostics Inc. (NASDAQ:LUCD) Receives $3.55 Average Target Price from AnalystsJune 19 at 1:29 AM | americanbankingnews.comMajor California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA TestJune 18, 2025 | prnewswire.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 39.3% in MayJune 16, 2025 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Given Consensus Rating of "Buy" by BrokeragesJune 16, 2025 | marketbeat.comAscendiant Capital Markets Forecasts Strong Price Appreciation for Lucid Diagnostics (NASDAQ:LUCD) StockJune 6, 2025 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Sees Large Increase in Short InterestJune 3, 2025 | marketbeat.comLucid Diagnostics to Join Russell 2000® and Russell 3000® IndexesMay 27, 2025 | prnewswire.comLucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Buy" from AnalystsMay 24, 2025 | marketbeat.comLucid Diagnostics’ SWOT analysis: stock faces reimbursement hurdles amid market potentialMay 21, 2025 | investing.comLucid Diagnostics Reports Increased Losses Amid Revenue DeclineMay 16, 2025 | tipranks.comEarnings call transcript: Lucid Diagnostics Q1 2025 highlights growth and strategic expansionMay 15, 2025 | investing.comPAVmed Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | prnewswire.comLucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call TranscriptMay 14, 2025 | seekingalpha.comLucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue EstimatesMay 14, 2025 | zacks.comLucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comWill Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should KnowMay 7, 2025 | zacks.comLucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025April 30, 2025 | prnewswire.comLucid Diagnostics’ EsoGuard DNA Test shows cancer detection efficacy in studyApril 26, 2025 | markets.businessinsider.comLucid Diagnostics Reports Positive Data for EsoGuard in Study of Asymptomatic PatientsApril 24, 2025 | theglobeandmail.comLucid reports encouraging results from EsoGuard studyApril 24, 2025 | msn.comNCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERDApril 24, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAEMD, GUTS, LUCD, and KRMD Company DescriptionsAethlon Medical NASDAQ:AEMD$1.58 -0.16 (-9.20%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.62 +0.04 (+2.53%) As of 06/20/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Fractyl Health NASDAQ:GUTS$2.14 +0.23 (+12.04%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.10 -0.04 (-1.87%) As of 06/20/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.KORU Medical Systems NASDAQ:KRMD$3.38 +0.13 (+4.00%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$3.42 +0.04 (+1.15%) As of 06/20/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Lucid Diagnostics NASDAQ:LUCD$1.26 0.00 (0.00%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.26 0.00 (0.00%) As of 06/20/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
